Not all nebulizers are created equal: Considerations in choosing a nebulizer for aerosol delivery during mechanical ventilation

References

• Sun Q, Chang W, Liu X, et al. Aerosol therapy during mechanical ventilation in intensive care units: a questionnaire-based survey of 2203 ICU medical staff in China. J Intens Med. 2022;2:189–194.
   Google Scholar
• Ehrmann S, Roche-Campo F, Sferrazza Papa GF, et al. Aerosol therapy during mechanical ventilation: an international survey. Intensive Care Med. 2013;39:1048–1056.
   PubMed Web of Science ®Google Scholar
• Ehrmann S, Roche-Campo F, Bodet-Contentin L, et al. Aerosol therapy in intensive and intermediate care units: prospective observation of 2808 critically ill patients. Intensive Care Med. 2016;42:192–201.
   PubMed Web of Science ®Google Scholar
• Duarte AG, Momii K, Bidani A. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response. Respir Care. 2000;45:817–823.
   PubMedGoogle Scholar
• Naughton PJ, Joyce M, Mac Giolla Eain M, et al. Evaluation of aerosol drug delivery options during adult mechanical ventilation in the COVID-19 era. Pharmaceutics. 2021;13:1574.
   PubMed Web of Science ®Google Scholar
• Moustafa IOF, ElHansy MHE, Al Hallag M, et al. Clinical outcome associated with the use of different inhalation method with and without humidification in asthmatic mechanically ventilated patients. Pulm Pharmacol Ther. 2017;45:40–46.
   PubMed Web of Science ®Google Scholar
• Moustafa IOF, MRA-A A, Al Hallag M, et al. Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients. Heart Lung. 2017;46:464–467.
   PubMed Web of Science ®Google Scholar
• Fernández Fernández E, Joyce M, O’Sullivan A, et al. Evaluation of aerosol therapy during the escalation of care in a model of adult cystic fibrosis. Antibiotics. 2021;10:472.
   Web of Science ®Google Scholar
• Luyt C-E, Clavel M, Guntupalli K, et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia. Crit Care. 2009;13:R200.
   PubMed Web of Science ®Google Scholar
• Fink JB. Reliability of mesh aerosol devices used during INHALE trial. J Aerosol Med Pulm Drug Deliv. 2022;35:107–108.
   PubMed Web of Science ®Google Scholar
• Rouby -J-J, Monsel A, Leone M, et al. The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: study design, aminoglycosides dosing and technique of nebulisation. Anaesth Crit Care Pain Med. 2020;39:179–183.
   PubMed Web of Science ®Google Scholar
• Olszewski OZ, MacLoughlin R, Blake A, et al. A silicon-based MEMS vibrating mesh nebulizer for inhaled drug delivery. Procedia Eng. 2016;168:1521–1524.
   Google Scholar
• Adorni G, Seifert G, Buttini F, et al. Aerosolization performance of jet nebulizers and biopharmaceutical aspects. Pharmaceutics. 2019;11:406.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ahuja A, Irvin CM, et al. Evaluation of nebulizer performance under various humidity conditions. J Aerosol Med. 2005;18:283–293.
   PubMedGoogle Scholar
• Hatley RH, Byrne SM. Variability in delivered dose and respirable delivered dose from nebulizers: are current regulatory testing guidelines sufficient to produce meaningful information? Med Devices. 2017;10:17–28.
   Google Scholar
• Longest W, Spence B, Hindle M. Devices for improved delivery of nebulized pharmaceutical aerosols to the lungs. J Aerosol Med Pulm Drug Deliv. 2019;32:317–339.
   PubMed Web of Science ®Google Scholar
• Hou H, Xu D, Dai B, et al. Position of different nebulizer types for aerosol delivery in an adult model of mechanical ventilation. Front Med. 2022;9:2819.
   Web of Science ®Google Scholar
• Wan G-H, Lin RRT, Fink JB, et al. In vitro evaluation of aerosol delivery by different nebulization modes in pediatric and adult mechanical ventilators. DOI:10.4187/respcare.02999.
   Google Scholar
• Dhand R, Sohal H. Pulmonary drug delivery system for inhalation therapy in mechanically ventilated patients. Expert Rev Med Devices. 2014;5(1):9–18.
   Google Scholar
• Michotte J-B, Staderini E, Aubriot A-S, et al. Pulmonary drug delivery following continuous vibrating mesh nebulization and inspiratory synchronized vibrating mesh nebulization during noninvasive ventilation in healthy volunteers. J Aerosol Med Pulm Drug Deliv. 2018;31:33–41.
   PubMed Web of Science ®Google Scholar
• Ben-Menahem SM, Nistor-Gallo R, Macia G, et al. How the new European regulation on medical devices will affect innovation. Nat Biomed Eng. 2020;4:585–590.
   PubMed Web of Science ®Google Scholar
• Li J, Fink JB, MacLoughlin R, et al. A narrative review on trans-nasal pulmonary aerosol delivery. Crit Care. 2020;24:506.
   PubMed Web of Science ®Google Scholar
• Galindo-Filho VC, Alcoforado L, Rattes C, et al. A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: a randomized controlled trial with radiolabeled aerosols. Respir Med. 2019;153:60–67.
   PubMed Web of Science ®Google Scholar
• Dugernier J, Hesse M, Jumetz T, et al. Aerosol delivery with two nebulizers through high-flow nasal cannula: a randomized cross-over single-photon emission computed tomography-computed tomography study. J Aerosol Med Pulm Drug Deliv. 2017;30:349–358.
   PubMed Web of Science ®Google Scholar
• Dubus JC, Vecellio L, de Monte M, et al. Aerosol deposition in neonatal ventilation. Pediatr Res. 2005;58:10–14.
   PubMed Web of Science ®Google Scholar
• Réminiac F, Vecellio L, MacLoughlin R, et al. Nasal high flow nebulization in infants and toddlers: an in vitro and in vivo scintigraphic study. Pediatr Pulmonol. 2017;52:337–344.
   PubMed Web of Science ®Google Scholar
• MacLoughlin R, Telfer C, Clark A, et al. Aerosol: a novel vehicle for pharmacotherapy in neonates. Curr Pharm Des. 2017;23:5928–5934.
   PubMed Web of Science ®Google Scholar
• Li X, Tan W, Zhao H, et al. Effects of jet nebulization on ventilator performance with different invasive ventilation modes: a bench study. Front Med (Lausanne). 2022;9:3024.
   Web of Science ®Google Scholar
• Joyce M, McGrath JA, Mac Giolla Eain M, et al. Nebuliser type influences both patient-derived bioaerosol emissions and ventilation parameters during mechanical ventilation. Pharmaceutics. 2021;13:199.
   PubMed Web of Science ®Google Scholar
• Wang R, Leime CO, Gao W, et al. Aerosol delivery in models of pediatric high flow nasal oxygen and mechanical ventilation. Pediatr Pulmonol. 2022. DOI:10.1002/ppul.26270.
   Web of Science ®Google Scholar
• Berlinski A, Willis JR. Effect of tidal volume and nebulizer type and position on albuterol delivery in a pediatric model of mechanical ventilation. Respir Care. 2015;60:1424–1430.
   PubMed Web of Science ®Google Scholar
• Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care. 2013;58:1124–1133.
   PubMed Web of Science ®Google Scholar
• Ari A, Fink JB. Inhalation therapy in patients with tracheostomy: a guide to clinicians. Expert Rev Respir Med. 2017;11 3 :201–208.
   PubMed Web of Science ®Google Scholar
• Harvey CJ, O’Doherty MJ, Page CJ, et al. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J. 1997;10:905–909.
   PubMed Web of Science ®Google Scholar
• Dugernier J, Ehrmann S, Sottiaux T, et al. Aerosol delivery during invasive mechanical ventilation: a systematic review. Crit Care. 2017;21:264.
   PubMed Web of Science ®Google Scholar
• Najlah M, Parveen I, Alhnan MA, et al. The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers. Int J Pharm. 2014;461:234–241.
   PubMed Web of Science ®Google Scholar
• Rossi I, Sonvico F, McConville JT, et al. Nebulized coenzyme Q 10 nanosuspensions: a versatile approach for pulmonary antioxidant therapy. Eur J Pharm Sci. 2018;113:159–170.
   PubMed Web of Science ®Google Scholar
• Hernández-Trejo N, Kayser O, Steckel H, et al. Characterization of nebulized buparvaquone nanosuspensions—effect of nebulization technology. J Drug Target. 2005;13:499–507.
   PubMed Web of Science ®Google Scholar
• Brady P, McKillop C, Joyce M, et al. P11.4 Choice of nebuliser type affects lung dosing with budesonide in both adult and paediatric patients during mechanical ventilation. Ir J Med Sci. 2018;187:237–303.
   Web of Science ®Google Scholar
• Job S, Kopuri A, Ives K, et al. PO-0743 Use of a new-generation electronic micropump nebuliser to deliver budesonide in chronic lung disease: a feasible alternative to systemic dexamethasone? Arch Dis Child. 2014;99:A498.2–A498.
   Google Scholar
• Hu J, Chen X, Li S, et al. Comparison of the performance of inhalation nebulizer solution and suspension delivered with active and passive vibrating-mesh device. J Drug Deliv Sci Technol. 2020;55:101353.
   Web of Science ®Google Scholar
• Amani A, Amini MA, Ali HSM, et al. Alternatives to conventional suspensions for pulmonary drug delivery by nebulisers: a review. J Pharm Sci. 2011;100:4563–4570.
   PubMed Web of Science ®Google Scholar
• Forest V, Pourchez J. Nano-delivery to the lung – by inhalation or other routes and why nano when micro is largely sufficient? Adv Drug Deliv Rev. 2022;183:114173.
   PubMed Web of Science ®Google Scholar
• Doroudian M, O’Neill A, O’Reilly C, et al. Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit Pseudomonas aeruginosa induced inflammation and biofilm formation. Nanomedicine. 2020;15(30):2933–2953. DOI:10.2217/nnm-2020-0344.
   PubMed Web of Science ®Google Scholar
• Bahlool AZ, Fattah S, O’Sullivan A, et al. Development of inhalable ATRA-loaded PLGA nanoparticles as host-directed immunotherapy against tuberculosis. Pharmaceutics. 2022;14:1745.
   PubMed Web of Science ®Google Scholar
• Verma NK, Crosbie-Staunton K, Satti A, et al. Magnetic core-shell nanoparticles for drug delivery by nebulization. J Nanobiotechnology. 2013;23(11):1. DOI:10.1186/1477-3155-11-1.
   Google Scholar
• Gaspar MM, Gobbo O, Ehrhardt C. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers. J Liposome Res. 2010;20(1):55–61.
   PubMed Web of Science ®Google Scholar
• Zhu YG, Meng SM, Monsel A, et al. Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Res Ther. 2022;13. DOI:10.1186/s13287-022-02900-5
   Web of Science ®Google Scholar
• Fernández Fernández E, Santos-Carballal B, de Santi C, et al. Biopolymer-based nanoparticles for cystic fibrosis lung gene therapy studies. Materials. 2018;11:122.
   PubMed Web of Science ®Google Scholar
• Sécher T, Bodier-Montagutelli E, Parent C, et al. Aggregates associated with instability of antibodies during aerosolization induce adverse immunological effects. Pharmaceutics. 2022;14:671.
   PubMed Web of Science ®Google Scholar
• Sidler-Moix AL, Di Paolo ER, Dolci U, et al. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model. Respir Care. 2015;60:38–46.
   PubMed Web of Science ®Google Scholar
• Sahakijpijarn S, Smyth HDC, Miller DP, et al. Post-inhalation cough with therapeutic aerosols: formulation considerations. Adv Drug Deliv Rev. 2020;165–166:127–141.
   PubMed Web of Science ®Google Scholar
• Tachiiri Y, Inoue S, Kawaguchi M. A case of thoracic pneumatosis due to severe coughs and tracheal tube displacement induced by tracheal tube size mismatch. JA Clin Rep. 2019;5:1–4.
   PubMed Web of Science ®Google Scholar
• Kamin W, Erdnüss F, Krämer I. Inhalation solutions — which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers — update 2013. J Cyst Fibros. 2014;13:243–250.
   PubMed Web of Science ®Google Scholar
• Krämer I, Schwabe A, Lichtinghagen R, et al. Physicochemical compatibility of mixtures of dornase alfa and tobramycin containing nebulizer solutions. Pediatr Pulmonol. 2009;44:134–141.
   PubMed Web of Science ®Google Scholar
• Berlinski A, Waldrep JC. Nebulized drug admixtures: effect on aerosol characteristics and albuterol output. J Aerosol Med. 2006;19(4):484–490. http://www.liebertpub.com/jam
   PubMedGoogle Scholar
• Katz SL, Ho SL, Coates AL. Nebulizer choice for inhaled colistin treatment in cystic fibrosis. Chest. 2001;119:250–255.
   PubMed Web of Science ®Google Scholar
• Bihan K, Zahr N, Becquemin M-H, et al. Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria. J Antimicrob Chemother. 2018;73:1639–1646.
   PubMed Web of Science ®Google Scholar
• Ghazanfari T, Elhissi AMA, Ding Z, et al. The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharm. 2007;339:103–111.
   PubMed Web of Science ®Google Scholar
• Brave H, MacLoughlin R. State of the art review of cell therapy in the treatment of lung disease, and the potential for aerosol delivery. Int J Mol Sci. 2020;21:6435.
   PubMed Web of Science ®Google Scholar
• Azhdari MH, Goodarzi N, Doroudian M, et al. Molecular insight into the therapeutic effects of stem cell-derived exosomes in respiratory diseases and the potential for pulmonary delivery. Int J Mol Sci. 2022;23:6273.
   PubMed Web of Science ®Google Scholar
• Pitiot A, Heuzé-Vourc’h N, Sécher T. Alternative routes of administration for therapeutic antibodies—state of the art. Antibodies. 2022;11:56.
   Web of Science ®Google Scholar
• Fröhlich E, Salar-Behzadi S. Oral inhalation for delivery of proteins and peptides to the lungs. Eur J Pharm Biopharm. 2021;163:198–211.
   PubMed Web of Science ®Google Scholar
• Chow MYT, Qiu Y, Lam JKW. Inhaled RNA therapy: from promise to reality. Trends Pharmacol Sci. 2020;41:715–729.
   PubMed Web of Science ®Google Scholar
• Chang RYK, Wallin M, Lin Y, et al. Phage therapy for respiratory infections. Adv Drug Deliv Rev. 2018;133:76–86.
   PubMed Web of Science ®Google Scholar
• Doroudian M,O, Neill A, Mac Loughlin R, et al. Nanotechnology in pulmonary medicine. Curr Opin Pharmacol. 2021;56:85–92.
   PubMed Web of Science ®Google Scholar
• Brennan LC, O’Sullivan A, MacLoughlin R. Cellular therapy for the treatment of paediatric respiratory disease. Int J Mol Sci. 2021;22:8906.
   PubMed Web of Science ®Google Scholar
• Daly S, O’Sullivan A, MacLoughlin R. Cellular immunotherapy and the lung. Vaccines (Basel). 2021;9:1018.
   PubMed Web of Science ®Google Scholar
• McCarthy SD, González HE, Higgins BD. Future trends in nebulized therapies for pulmonary disease. J Pers Med. 2020;10:37.
   PubMed Web of Science ®Google Scholar
• Masterson CH, McCarthy SD, O’Toole D, et al. The role of cells and their products in respiratory drug delivery: the past, present, and future. Expert Opin Drug Deliv. 2020;17:1689–1702.
   PubMed Web of Science ®Google Scholar
• Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat Sean D. McCarthy, Christopher B. Rohde, Matt Angel, Claire H. Masterson, Ronan MacLoughlin, Juan Fandiño, Héctor E. González, Declan Byrnes, John G. Laffey, and Daniel O'Toole Nucleic Acid Therapeutics 0 0:0 DOI :10.1089/nat.2022.0049.
   Google Scholar
• Vatzia E, Feest K, McNee A, et al. Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs. npj Vaccines. 2013;8:19. DOI :10.1038/s41541-023-00620-2.
   Google Scholar
• Klockare M, Dufva A, Danielsson A-M, et al. Comparison between direct humidification and nebulization of the respiratory tract at mechanical ventilation: distribution of saline solution studied by gamma camera. J Clin Nurs. 2006;15:301–307.
   PubMed Web of Science ®Google Scholar
• Dugernier J, Reychler G, Wittebole X, et al. Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Ann Intensive Care. 2016;6:73.
   PubMed Web of Science ®Google Scholar
• MacLoughlin R, Champigny C, Montharu J, et al. Aerosol deposition in a mechanically ventilated ex vivo porcine lung using a vibrating mesh nebuliser and a pressurized metered dose inhaler. Drug Delivery to the Lungs Conference; 2022. https://ddl-conference.com/ddl2022/conference-papers/aerosol-deposition-in-a-mechanically-ventilated-ex-vivo-porcine-lung-using-a-vibrating-mesh-nebuliser-and-a-pressurized-metered-dose-inhaler/. accessed 2022 Dec 10.
   Google Scholar
• Greenblatt EE, Winkler T, Harris RS, et al. What causes uneven aerosol deposition in the bronchoconstricted lung? a quantitative imaging study. J Aerosol Med Pulm Drug Deliv. 2016;29:57–75.
   PubMed Web of Science ®Google Scholar
• Darquenne C. Aerosol deposition in health and disease. J Aerosol Med Pulm Drug Deliv. 2012;25:140–147.
   PubMed Web of Science ®Google Scholar
• Darquenne C, Fleming JS, Katz I, et al. Bridging the gap between science and clinical efficacy: physiology, imaging, and modeling of aerosols in the lung. J Aerosol Med Pulm Drug Deliv. 2016;29(2):107–126.
   PubMed Web of Science ®Google Scholar
• Mairinger S, Hernández-Lozano I, Zeitlinger M, et al. Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition. Expert Opin Drug Deliv. 2022;19:1561–1575.
   PubMed Web of Science ®Google Scholar
• Man F, Tang J, Swedrowska M, et al. Imaging drug delivery to the lungs: methods and applications in oncology. Adv Drug Deliv Rev. 2023;192:114641.
   PubMed Web of Science ®Google Scholar
• Bennett WD, Wu J, Fuller F, et al. Duration of action of hypertonic saline on mucociliary clearance in the normal lung. J Appl Physiol. 2015;118:1483–1490.
   PubMed Web of Science ®Google Scholar
• Sadiq MW, Holz O, Ellinghusen BD, et al. Lung pharmacokinetics of inhaled and systemic drugs: a clinical evaluation. Br J Pharmacol. 2021;178:4440–4451.
   PubMed Web of Science ®Google Scholar
• Kyriakoudi A, Pontikis K, Valsami G, et al. Pharmacokinetic characteristics of nebulized colistimethate sodium using two different types of nebulizers in critically ill patients with ventilator-associated respiratory infections. Antibiotics. 2022;11:1528.
   Google Scholar
• Karaiskos I, Souli M, Galani I, et al. Colistin: still a lifesaver for the 21st century? Expert Opin Drug Metab Toxicol. 2017;13:59–71.
   PubMed Web of Science ®Google Scholar
• Sachdev A, Sagar N, Gupta D, et al. Efficacy of adjuvant colistimethate sodium nebulization in ventilator associated pneumonia in pediatric intensive care unit – a randomized controlled study. J Pediatric Crit Care. 2019;6:15.
   Google Scholar
• Pourheidar E, Haghighi M, Kouchek M, et al. Comparison of intravenous ampicillin-sulbactam plus nebulized colistin with intravenous colistin plus nebulized colistin in treatment of ventilator associated pneumonia caused by multi drug resistant Acinetobacter baumannii: randomized open label trial. Iranian J Pharm Res. 2019;18:269–281.
   Google Scholar
• Lu Q, Luo R, Bodin L, et al. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Anesthesiology. 2012;117:1335–1347.
   PubMed Web of Science ®Google Scholar
• Gkoufa A, Sou T, Karaiskos I, et al. Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia. Int J Antimicrob Agents. 2022;59:106588.
   PubMed Web of Science ®Google Scholar
• Rashid J, Absar S, Nahar K, et al. Newer devices and improved formulations of inhaled insulin. Expert Opin Drug Deliv. 2015;12(6):917–928.
   PubMed Web of Science ®Google Scholar
• Elnadoury O, Beattie J, Lubinsky AS. Uninterrupted continuous and intermittent nebulizer therapy in a COVID-19 patient using sequential vibratory mesh nebulizers: a case report. J Aerosol Med Pulm Drug Deliv. 2020;33:357–360.
   PubMed Web of Science ®Google Scholar
• Li J, Augustynovich AE, Gurnani PK, et al. In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients. Respir Res. 2021;22:1–10.
   PubMed Web of Science ®Google Scholar
• Drwiega EN, Rodvold KA. Penetration of antibacterial agents into pulmonary epithelial lining fluid: an update. Clin Pharmacokinet. 2022;61:17–46.
   PubMed Web of Science ®Google Scholar
• Rodvold KA, George JM, Yoo L. Penetration of anti-infective agents into pulmonary epithelial lining Fluid. Clin Pharmacokinet. 2011;50:637–664.
   PubMed Web of Science ®Google Scholar
• Kiem S, Schentag JJ. Interpretation of epithelial lining fluid concentrations of antibiotics against methicillin resistant Staphylococcus aureus. Infect Chemother. 2014;46:219.
   PubMedGoogle Scholar
• Mukker JK, Singh RSP, Derendorf H. Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy. Adv Drug Deliv Rev. 2015;85:57–64.
   PubMed Web of Science ®Google Scholar
• Desgrouas M, Ehrmann S. Inhaled antibiotics during mechanical ventilation—why it will work. Ann Transl Med. 2021;9:598.
   PubMed Web of Science ®Google Scholar
• Asmus MJ, Stewart BA, Milavetz G, et al. Tobramycin as a pharmacologic tracer to compare airway deposition from nebulizers. Pharmacotherapy. 2002;22:557–563.
   PubMed Web of Science ®Google Scholar
• Al-Amoud AI, Clark BJ, Assi KA, et al. Determination of the bioavailability of gentamicin to the lungs following inhalation from two jet nebulizers. Br J Clin Pharmacol. 2005;59:542–545.
   PubMed Web of Science ®Google Scholar
• Moraine -J-J, Truflandier K, Vandenbergen N, et al. Placement of the nebulizer before the humidifier during mechanical ventilation: effect on aerosol delivery. Heart Lung. 2009;38:435–439.
   PubMed Web of Science ®Google Scholar
• Dunne RB, Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. Am J Emerg Med. 2018;36:641–646.
   PubMed Web of Science ®Google Scholar
• Moody GB, Luckett PM, Shockley CM, et al. Clinical efficacy of vibrating mesh and jet nebulizers with different interfaces in pediatric subjects with asthma. Respir Care. 2020;65:1451–1463.
   PubMed Web of Science ®Google Scholar
• Mac Giolla Eain M, Joyce M, MacLoughlin R. An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient. Drug Deliv. 2021;28:1496–1500.
   PubMed Web of Science ®Google Scholar
• O’Toole C, McGrath JA, Joyce M, et al. Fugitive aerosol therapy emissions during mechanical ventilation: in vitro assessment of the effect of tidal volume and use of protective filters. Aerosol Air Qual Res. 2020;20:2604–2613.
   Web of Science ®Google Scholar
• Fink JB, Ehrmann S, Li J, et al. Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv. 2020;33:300–304.
   PubMed Web of Science ®Google Scholar
• Cinesi Gómez C, Rodríguez Ó P, Luján Torné M, et al. Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2. Arch Bronconeumol. 2020;56:11–18.
   PubMedGoogle Scholar
• Respiratory Care Committee of Chinese Thoracic Society. Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:288–296.
   PubMedGoogle Scholar
• British Thoracic Society. COVID-19: information for the respiratory community | British Thoracic Society | better lung health for all, https://www.brit-thoracic.org.uk/covid-19/covid-19-information-for-the-respiratory-community/ accessed 2022 Aug 2.
   Google Scholar
• Kumar P, Kulkarni AP, Govil D, et al. Airway management and related procedures in critically ill COVID-19 patients: position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med. 2020;24(8): 630–642 . DOI:10.5005/jp-journals-10071-23471.
   PubMed Web of Science ®Google Scholar
• Federazione delle Associazioni dei Dirigenti Ospedalieri Internisti. COVID-19 | GUIDA CLINICO-PRATICA FADOI FADOI è orgogliosa di presentare la Guida Clinico-Pratica sull’infezione da SARS-CoV-2 in italiano, completa di bibliografia, a cura del Gruppo Giovani FADOI [cited 2023 Feb 01]. Available from:www.fadoi.org
   Google Scholar
• GOLD Science Committee. Global Strategy For the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease - Report 2022. 2022. https://goldcopd.org/wp-content/uploads/2021/11/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf, accessed 2022 Nov 29.
   Google Scholar
• Craven DE, Lichtenberg DA, Goularte TA, et al. Contaminated medication nebulizers in mechanical ventilator circuits. Am J Med. 1984;77:834–838.
   PubMed Web of Science ®Google Scholar
• Swanson CS, Dhand R, Cao L, et al. Microbiome profiles of nebulizers in hospital use. J Aerosol Med Pulm Drug Deliv. 2022;35:212–222.
   PubMedGoogle Scholar
• Monforte V, Román A, Gavaldà J, et al. Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation. Transplant Proc. 2005;37:4056–4058.
   PubMed Web of Science ®Google Scholar